Madera, Melanie D.
HRN: 22-80-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2023
CEFTRIAXONE 1G (VIAL)
03/20/2023
03/26/2023
IV
1 G
Q12
T/C Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes